Joseph W La Plume Charles River Laboratories International, Inc. (CRL) insider trading activity

Joseph W La Plume is EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 25,316 shares of CRL, which is worth approximately $3.82 Million. The most recent transaction as insider was on Jan 28, 2022, when has been sold 11,344 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.3K

26.5% 3M change

4.18% 12M change

Total Value Held $3.82 Million

Joseph W LaPlume Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 28 2022	BUY Grant, award, or other acquisition	-	11,344 Added 30.06%	26,395 Common Stock
Dec 25 2021	BUY Grant, award, or other acquisition	-	6,771 Added 31.03%	15,051 Common Stock
Nov 22 2021	SELL Bona fide gift	-	182 Reduced 2.15%	8,280 Common Stock
Aug 06 2021	SELL Open market or private sale	$1,493,320 $403.6 p/Share	3,700 Reduced 30.42%	8,462 Common Stock
May 29 2021	SELL Payment of exercise price or tax liability	$75,372 $337.99 p/Share	223 Reduced 1.8%	12,162 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	-	1,124 Added 8.32%	12,385 Common Stock
Feb 25 2021	SELL Open market or private sale	$2,463,095 $281.98 p/Share	8,735 Reduced 43.68%	11,261 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	$242,138 $88.05 p/Share	2,750 Added 12.09%	19,996 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$91,120 $282.98 p/Share	322 Reduced 1.83%	17,246 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$89,331 $283.59 p/Share	315 Reduced 1.76%	17,568 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$91,787 $289.55 p/Share	317 Reduced 1.74%	17,883 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$1,228,223 $260.88 p/Share	4,708 Reduced 20.55%	18,200 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	11,862 Added 34.12%	22,908 Common Stock
Dec 01 2020	SELL Bona fide gift	-	310 Reduced 2.73%	11,046 Common Stock
Nov 04 2020	SELL Open market or private sale	$1,685,896 $250.17 p/Share	6,739 Reduced 37.24%	11,356 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$768,381 $114.02 p/Share	6,739 Added 27.14%	18,095 Common Stock
Jun 17 2020	SELL Bona fide gift	-	285 Reduced 2.45%	11,356 Common Stock

JWL

Joseph W La Plume

EVP, Corp Strategy & Develop

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account